The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome

Clinical trial NCT00357097 · COMPLETED

Trial details

NCT number: NCT00357097
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Restless Legs Syndrome Moderate to Severe Idiopathic Restless Legs Syndrome (RLS)

Start date: 2006-06-01
Primary completion: 2007-12-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.